Editorial: calcineurin inhibitors as a bridge to vedolizumab for severe ulcerative colitis
1Jill Roberts Center for IBD, Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, NY, USA.
Alimentary Pharmacology & Therapeutics
|February 27, 2020
Abstract
No abstract available in PubMed .
More Related Videos
08:27Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
8.0K
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
12.7K
